Piper Sandler Maintains Overweight on Prothena Corp, Raises Price Target to $36
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Yasmeen Rahimi maintains Prothena Corp (NASDAQ:PRTA) with a Overweight and raises the price target from $15 to $36.
Piper Sandler analyst Yasmeen Rahimi maintains Prothena Corp (NASDAQ:PRTA) with a Overweight and raises the price target from $15 to $36.